SENATE DOCKET, NO. 400        FILED ON: 1/19/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 994

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Steven A. Tolman

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to eliminate the abuse of controlled-release oxycodone..

_______________

PETITION OF:

 

Name:

District/Address:

Steven A. Tolman

 


SENATE DOCKET, NO. 400        FILED ON: 1/19/2011

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 994

By Mr. Tolman, petition (accompanied by bill, Senate, No. 994) of Tolman for legislation to eliminate the abuse of controlled-release oxycodone [Joint Committee on Mental Health and Substance Abuse].

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 753 OF 2009-2010.]

 

The Commonwealth of Massachusetts

 

_______________

In the Year Two Thousand Eleven

_______________

 

An Act to eliminate the abuse of controlled-release oxycodone..

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Chapter 94C of the General Laws, as appearing in the 2002 Official Edition, is hereby amended by inserting after section 3 the following section:-

          Section 3A.  Notwithstanding sections 2 and 3, any preparation which contains oxycodone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts, shall be in schedule I.

SECTION 2.  Section 31 of said chapter 94C of the General Laws, as so appearing, is hereby amended by inserting  after  line 85, the following paragraph:-

(d) Any preparation, which contains oxycodone, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers, if manufactured so as delay absorption into the blood system, unless the preparation contains 1 or more active nonnarcotic ingredients in recognized therapeutic amounts.